From housekeeper to microsurgeon: the diagnostic and therapeutic potential of ribonucleases

Nature Biotechnology
C H Schein

Abstract

The RNA population in cells is controlled post-transcriptionally by ribonucleases (RNases) of varying specificity. Angiogenin, neurotoxins, and plant allergens are among many proteins with RNase activity or significant homology to known RNases. RNase activity in serum and cell extracts is elevated in a variety of cancers and infectious diseases. RNases are regulated by specific activators and inhibitors, including interferons. Many of these regulatory molecules are useful lead compounds for the design of drugs to control tumor angiogenesis, allergic reactions, and viral replication. One RNase (Onconase) and several RNase activators are now in clinical trials for cancer treatment or inhibition of chronic virus infections. Several others, alone or conjugated with specific cell binding molecules, are being developed for their antifungal, antiviral, and antitumor cell activity.

References

Nov 3, 1975·Biochemical and Biophysical Research Communications·K K Reddi
Dec 15, 1975·European Journal of Biochemistry·J BartholeynsP Baudhuin
Jul 1, 1992·Experimental Eye Research·C E CrossonD M Lam
Jan 15, 1992·The Biochemical Journal·D F LappinK Whaley
Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K N Morris, I G Wool
Dec 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A Hertler, A E Frankel
Jan 1, 1983·The International Journal of Biochemistry·D K Liu, G F Owens
Feb 14, 1994·FEBS Letters·C NakaiS Kanaya
Mar 1, 1994·Molecular Microbiology·J Chow, P P Dennis
Nov 1, 1994·The American Journal of Physiology·F BesançonA Edelman
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·A WennborgA von Gabain
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·P Lengyel
Nov 15, 1993·FEBS Letters·P Bork, C Sander
Dec 1, 1994·Current Opinion in Structural Biology·J Hofsteenge
Nov 1, 1994·Molecular Microbiology·B PyC F Higgins
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J YouleM Gravell
Aug 1, 1994·Archives of Biochemistry and Biophysics·D NadanoK Kishi

❮ Previous
Next ❯

Citations

Oct 31, 2012·ACS Applied Materials & Interfaces·He ShenZhijun Zhang
Dec 24, 1997·Nature·S J GriffithsS J Talbot
Dec 5, 1998·Journal of the National Cancer Institute·D L Newton, S M Rybak
Feb 1, 2003·Nucleic Acids Research·Marcia C HaigisRonald T Raines
Jun 2, 2006·Nucleic Acids Research·Nicoletta PotenzaAniello Russo
Aug 3, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Marina de LeeuwOrna Almog
Jan 12, 2005·Clinical and Diagnostic Laboratory Immunology·Min LinJohn Pasick
Feb 17, 2011·Immunotherapy·Carima AndradyKerry A Chester
Jan 18, 2014·International Journal of Molecular Sciences·Kyle S Landry, Robert E Levin
Jul 7, 2009·Annual Review of Plant Biology·Yijing ZhangYongbiao Xue
Dec 1, 2001·Expert Opinion on Biological Therapy·D L Newton, S M Ryback
Sep 17, 2010·Biochimica Et Biophysica Acta·Evandro Fei Fang, Tzi Bun Ng
Jun 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Leizhen WeiLi Lan
Oct 20, 2007·Diabetes Research and Clinical Practice·G KocicS Stojanovic
May 23, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Gordana KocicSvetlana Stojanovic
Feb 14, 2012·The FEBS Journal·Marianna N KiritsiDiamantis C Sideris
Aug 22, 2006·Journal of Molecular Biology·Bryan D Smith, Ronald T Raines
Dec 10, 1999·Experimental Cell Research·S M Rybak, D L Newton
Jan 1, 2013·Biochimie·Ester BoixMohammed Moussaoui
Feb 27, 1999·Experimental Cell Research·M R SmithS M Rybak
Mar 17, 2010·Molecular Cell·Yide MeiXiaolu Yang
May 19, 2001·Chemistry & Biology·P A Leland, R T Raines
Jun 24, 1998·Journal of Molecular Biology·C N PaceG R Grimsley
Mar 30, 1999·Nature Biotechnology·R W Wagner, D Lipovsek
Apr 29, 2016·Journal of the American Heart Association·Eike KleinertSonja Guethoff
Aug 2, 2006·Molecular BioSystems·Antoni BenitoMaria Vilanova
Aug 23, 2019·Medicinal Research Reviews·Catherine H Schein
Jan 22, 2002·The Journal of Biological Chemistry·Marcia C HaigisRonald T Raines

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.